Amyotrophic Lateral Sclerosis
- 19 October 2017
- journal article
- letter
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 377 (16), 1602
- https://doi.org/10.1056/nejmc1710379
Abstract
The article by Brown et al. (July 13 issue)1 provides a comprehensive review of the mechanisms, pathophysiological processes, and clinical features of amyotrophic lateral sclerosis (ALS). However, although the options for disease-modifying treatment for ALS are limited, the importance of multidisciplinary symptom-based management, which may increase survival and improve quality of life, should be emphasized.2Keywords
This publication has 5 references indexed in Scilit:
- Amyotrophic Lateral SclerosisThe New England Journal of Medicine, 2017
- Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patientsPLOS ONE, 2017
- Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort studyThe Lancet Neurology, 2015
- Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)Neurology, 2009
- Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000Journal of Neurology, Neurosurgery & Psychiatry, 2003